Drugs / BMMNC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01883661 | Jun 2014 → Nov 2016 | multiple sclerosis | Chaitanya Hospital, Pune | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMMNC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01883661 ↗ |
| Known as | MNCs | “Bone Marrow derived Mono Nuclear Stem Cell (MNCs) by intravenously route total 3 doses in one month period .” NCT01883661 ↗ |
| Modality | Cell therapy | “Bone Marrow derived Mono Nuclear Stem Cell (MNCs)” NCT01883661 ↗ |
| Route | Intravenous | “by intravenously route” NCT01883661 ↗ |